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Abstract: The significance of the low attenuation area (LAA) of the lungs on high
resolution computed tomography (HRCT) has not been determined in patients with
asthma.
We examined the relationship between the percentage of lung area with CT numbers
lower than -950HU (%LAA) and the mean CT number in 81 patients with reversible
airway obstruction (asthma) and in 22 healthy subjects, as well as the relationship
between maximal %LAA and various parameters of pulmonary function, smoking
history, disease severity and allergic type in the asthmatic subjects. The mean CT
number was obtained by scans at three anatomic levels, and maximal %LAA was the
%LAA which had the largest value of those measured at the three anatomic levels of
the lung.
We found that: 1. The mean CT number was closely related to the maximal %LAA
of the lungs in all subjects studied (r= -0.916, p<O.OOO1). 2. The maximal %LAA in
asthmatics with a previous smoking history (median: 20.1) was significantly larger
than that in asthmatics without a smoking history (median: 10.8), and that in healthy
subjects with (median: 8.8) and without a history of smoking (median: 10.4). 3. The
maximal %LAA was significantly correlated with FEV1/FVC (r=-0.611, p<O.OOO1)
and TLC (r=0.391, p=0.0068) in the asthmatic subjects. 4. The maximal %LAA was
significantly correlated with the severity of asthma (p<O.01), but not with the
etiology of asthma.
This study suggests that the maximal %LAA is influenced by disease severity in
patients with asthma, and that a smoking history has a more significant effect on the
pulmonary function of asthmatics than healthy individuals.
Key Words : low attenuation area, high resolution computed tomography,
reversible airway obstruction
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Introduction
Asthma is a disease characterized by chron-
ic airway inflammation. Inflammatory cells,
especially activated Tcells and eosinophils I) ,
and chemical mediators such as histamine,
leukotrienes 2) and various cytokines released
from these cells,· play important roles at
allergic reaction sites in the airway. This
inflammation process leads to abnormalities
of the airway including an increase in muscle
massa 4), mucous gland hypertrophy 4) , and
reorganization of the extracellular matrix 5) •
Frequent airway and lung parenchymal
changes in asthma are considered to be re-
sponsible for irreversibility of airway .ob-
struction, which is observed in many severe
asthmatics. Thus, features of airway recon-'
struction such as bronchial wall thickening,
bronchiectasis, emphysema and mosaic pat-
terns of lung attenuation, have been observed
by high resolution computed tomography
(HRCT) in patients with asthma"' 1). Patients
with nonallergic asthma have more extensive
remodelling of the airways than those with
allergic asthma8\ and asthmatics with abnor-
mal HRCT findings demonstrate poorer lung
function and less hyperresponsive bronchi
than those with normal HRCT findings').
The relative area of the lungs with at-
tenuation values less than - 950 Hounsfield
Units (HU) (LAA, low attenuation area) on
high resolution CT scans obtained at full
inspiration is an objective measure of the
extent of pulmonary· emphysemalo.ll). A previ-
ous study suggested that the percentage of
pixels below -900 HU is significantly corre-
lated with pulmonary function, and reflects
air trapping in ·asthmatic patients l2J • How-
ever, the significance of the %LAA of the
lungs. on HRCT scans has not' been
determined in patients with asthma. In the
present study, we investigated the influence
of smoking history and asthma type and
severity to the percentage of lung area with
CT numbers lower than --'-950HU (%LAA) in
asthmatic patients.
Subjects and Methods
Subjects
The subjects in this study were 81 asthmat-
ics (39 females and 42 males) who were 21 to
81 years of age (median, 65 years). Thirty-
two of the asthmatics were former cigarette
smokers with a smoking history of 30.9 ±
23.9 pack-years (mean ± SD). Asthma was
diagnosed according to the criteria of the
International Consensus On Diagnosis and
Management of Asthma 13). All of the asth-
matic subjects have episodic symptoms of
wheezing and coughing, and experience symp-
tomatic relief and reversible airway response
with increases of forced expiratory volume in
one second (FEV!) exceeding 15% upon treat-
ment with beta-adrenergic agonists. The onset
and duration of asthma were established on
the basis of the patient's history, followed
by a careful examination. Allergy was diag-
nosed by clinical history, skin tests and the
presence of serum IgE antibodies specific to
common inhalant allergens. The serum level
of total IgE was measured by a radi-
oimmunosorbent test CRIST), and the pres-
ence of serum IgE antibodies specific to
inhalant allergens was estimated by the
Phadebas radioallergosorbent tesf [RAST®]
of the CAP systein® ·(Pharmacia Diagnostics
AB, Uppsala, Sweden). IgE antibodies against
inhalant allergens were found in 45 of the 81
asthmatic patients (55.6%). We defined
allergic patients as those who had· a positive
skin test and/or IgE specific to. the common
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inhalant allergens. The other patients were
classified as .nonallergic.
The clinical severity of asthma was evalu-
ated by the Aas scoring system, which is used
to grade chronic asthma from' very mild to
severe formsH). It has been reported that the
Aas score is significantly correlated with the
value of FEV1 '51 , and with airway inflamma-
tion in asthma'~ 16).
We also studied 22 adult control subjects
who had no history of allergic or respiratory
disease. They included 12 male subjects who
had a smoking history ranging between 15
and 150 pack-years (mean ± SD : 48.6 ± 37.3
pack-years), and 10 female subjects who had
never smoked.
Informed consent for the study protocol
was obtained from all subjects. The study
protocol was approved by the Ethics Commit-
tee of our institution. All patients were
~ .
studied at a time when there was no evidence
of asthma exacerbation or respiratory tract
infection.
Study design
The CT scan study was performed on the
same day as lung function measurements. The
value of the maximal %LAA was compared
with various parameters of pulmonary func-
tion, disease severity and allergic type in the
asthmatic subjects.
Pulmonary function tests
All pulmonary function tests were per-
formed using a CHESTAC 33 (Chest Co.,
Tokyo, Japan) linked to a computer. All
subjects underwent measurements of' pulmo-
nary function including: forced expiratory
volume in one second (FEVl), forced vital
capacity (FVC) and flow"volume curve. Total
lung capacity (TLC) was measured by the
helium dilution method. The diffusing capac-
ity ,for carbon monoxide (DLco) was
measured by the single breath method.
Computed tomography
All subjects had a modified HRCT scan of
the chest with a TOSHIBA Xpeed scanner
(TOSHIBA, Tokyo, Japan) using the thin
section (2 mm collimation) technique and a
high resolution (bone) reconstruction algo-
rithm. An intravenous contrast medium was
not administered. The scanning time was 2.7
seconds, tube current was 200 mAs, and
voltage was 120 kVp. HRCT was performed
in subjects holding their breath at full inspi-
ration, and was reconstructed with a bone
algorithm. End inspiratory scans were ob-
tained at the following three selected anat-
omic levels as described by Miniati, et al. 17) :
l) top of the aortic arch, 2) origin of the
lower lobe bronchus, and 3) 3cm above the
top of the diaphragm. Each inspiratory
HRCT scan was evaluated quantitatively by
measuring the percentage of lung area with
CT number < - 950 HU (%LAA), and the
mean CT number expressed in HU. The low
attenuation area «-950 HU) which had the
largest value among those at the three differ-
ent levels of the lung, was taken to be the
maximal %LAA in each subject. The mean
-CTnumber was calculated from the CT
numbers at the three anatomical lung levels.
Statistical Analysis
Correlation between any two variables was
determined using the nonparametric Spear-
man's correlation coefficient when possible.
Differences between medians were tested with
the Mann-Whitney U test for two independ-
ent samples. One-and two-way analyses of
variance (ANOVA) were used to compare the
maximal %LAA of· the asthmatic patients
classified by the severity of asthma (Aas
score) and allergic type. A p value of <0.05
was regarded as significant.
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r=-0.916 ))<0.000 I
n=103
• : asthma patients
o :healthy controls
Fig. 1. Relationship between the mean inspi-
ratory CT number (HU) and maxi-
mal %LAA (the percentage of lung
area with attenuation values less
than - 950 HU which had the largest
value among 3 slices on HRCT)
a?1ong the asthmatic and control
subjects.
-850 -800
mean inspiratory CT number (HU)
range: 2.0 to 41.7) was significantly higher
than that in asthmatics without a smoking
history (median: 10.8, range: 0.1 to 36.6),
and that in healthy subjects with (median:
8.8, range: 2.0 to 36.1) and without a history
of smoking (median: lOA, range: 1.1 to
18.8), as shown in Figure 2. These results
suggest that a smoking history has a signifi-
cant effect on the maximal %LAA of asth-
matics.
We observed significant correlations be-
tween maximal %LAA on HRCT and various
pulmonary function tests in the asthmatic
subjects. In particular, maximal %LAA was
closely correlated with FEV1/FVC (r=
-0.611, p<O.OOO1) (Figure 3-a) and TLC
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Table 1 shows the characteristics of the
subjects classified by smoking history and
asthma type. The asthma patients were
classified into 4 groups according to smoking
history and asthma type. Among the asth-
matics without a smoking history, the pa-
tients with allergic asthma were significantly
younger than those with nonallergic asthma
(median:57.0 and 67.0 years, respectively;
p<0.05). The age of onset of asthma was
also significantly younger in patients with
allergic asthma than in those with non-
allergic asthma (median:45.0 and 55.0 years,
respectively; p<O.01). The duration of
asthma was not significantly different among
the allergic and nonallergic asthmatics with
and without a smoking history. The age of
the asthmatic and healthy subjects did- not
differ significantly.
Table 1. Characteristics of the patients
Results
Computed Tomography
There was a significant correlation between
the maximal %LAA and the mean CT num-
ber among the normal and asthmatic sub-
jects, as shown in Figure 1 (Spearman's rank
correlationcoefficient:r= ~0.916, p<O.OOO1).
The maximal %LAA in the asthmatics with
a previous smoking history (median: 20.1,
Smoking Asthma Patienb Age- Ageal Duration or
Jlbtory type (n) (yT) oBse'· (yr) as.hma- (yr)
Bronchial Nevenmoker Atopy 22 57+ 45' II
asthma (21-78) (4-69) (1-39)
NonaloPY 27 67' 55' 9
(47-81) (28-75) (ll-30)
Smoker Alopy 23 65 52 io.
(47-79) (4-71) (2-63)
Nonatopr 64 53 12
(53-72) (22-71) (1·31)
Hultby control Nevenmoker NA 10 68.5 NA NA
(59-72)
Smoker NA 12 67.5 NA NA
(59·72)
AbbTDiwions: NA = nol available
4 RcsuIli are c:rpre55ed u median liDd ranee.
t p<O.05
* p<o.OI
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(r=0.391, p=O.0068) (Figure 3-b) , but was
not correlated with %FVC (Figure 3-c) nor
DLco (Figure 3-d) in patients with asthma.
• : previous smoker
o :neversmoker
r=0.391
IFO.0068
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Comparison of the maximal %LAA
on the inspiratory CT scans of 22
control subjects and 81 patients with
asthma, according to smoking his-
tory. The solid horizontal line indi-
cates the median of maximal %LAA
in each group. * p<O.Ol.
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There was a significant correlation between
maximal %LAA and disease severity as
assessed by the Aas score among the allergic
asthma patients and among the nonallergic
asthma patients (ANOVA, p<O.Ol).Among
the allergic asthma cases, the maximal
%LAA in patients with severe asthma (me-
dian: 16.8, range: 3.7 to 36.6) was signifi-
cantly larger than that in patients with mild
asthma (median: 6.0, range: 0.1 to 13.7)
(p<O.Ol). There was also a significant
2
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Maximal %LAA
Fig. 3-b.
Relationship between the maximal %LAA
and the pulmonary function of asthmatics.
Maximal %LAA was significantly corre-
lated with (a) FEV1/FVC and (b) TLC,
but not with (c) %FVC, or (d) DLco
among all asthmatics.
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Fig. 4. Maximal %LAA of the asthmatic
subjects according to the severity and
etiology of asthma. Aas scores 1 and
2, and 4 and 5, were pooled. Maxi-
mal %LAA showed significant corre-
lation with the severity of asthma
(p<O.Ol), but not with the type of
asthma.
The solid horizontal line indicates
the median of maximal %LAA in
each group. The correlation was
analyzed by ANOV A (analysis of
variance) .
• : atopic asthma
a :oooatollic asthma
difference in the maximal %LAA of patients
wi th nonallergic. severe asthma and pa tien ts
with nonallergic. mild asthma. However, no
significant difference in maximal %LAA was
found between allergic and nonallergic asth-
matic subjects with the same severity of
asthma (Figure 4).
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Discussion
Comparison of computed tomography (CT)
images with pathologic features of emphy-
sema in autopsy and surgical lung specimens
has strongly suggested that CT is the most
accurate imaging method for diagnosing
emphysema18- 23). The relative area of the lung
with attenuation values < -950 HU on HRCT
scans can be used for evaluation and diagno-
sis of emphysema1~11). Thus, it is generally
agreed that CT scanning is a sensitive tech-
nique for detecting emphysematous lesions 24) ;
however, CT quantification of pulmonary
emphysema may be affected by hyperinflation
and nonemphysematous expiratory airflow
limitation, factors which have not yet been
investigated 25) .
Patients with asthma show more abnor-
malities related to airways remodelling on
HRCT than normal subjects6• 71 • Airways
remodelling is more often found in patients
with nonallergic asthma than in those with
allergic asthma8). The significance of the size
of the low attenuation area of the lungs on
HRCT has been controversial in asthma.
Gevenois, et al., did not find any significant
change in CT lung density parameters with
respect to the size of the low attenuation
area (LAA) of the lungs « ~ 950 HU) dur-
,ing allergic challenge tests, despite a decrease
in FEV1 of 0.91 associated with an increase
in residual volume (RV) and functional
residual capacity (FRC) of about the same
volume. They concluded that hyperinflation
and airflow obstruction without emphysema-
tous lung destruction would not influence
densitometric measurements obtained from
inspiratory scans""). Newman, et al., found
that inspiratory HRCT scans obtained in the
lower area (the level of the diaphragm,
LAA< ~ 900 HU) in asthmatics and non-
asthmatic subjects, did not differ signifi-
cantly ; however, those obtained in the upper
area (the level of the transverse aorta, LAA
< - 900 HU) did differ significantly 12).
In this study, the maximal %LAA of three
anatomic lung levels was examined in pa-
tients with reversible airway obstruction. The
results obtained here demonstrate that maxi-
mal %LAA is closely related to the mean CT
number not only in asthma patients but also
in normal subjects. The mean CT number is
linearly related to the fraction of air in the
lungs, i.e., the ratio of the volume of air to
the volume of air plus the volume of
tissue 27). The maximal %LAA in asthmatic
patients with a history of smoking was
significantly larger than that in asthmatics
without a history of smoking and those of
the control subjects. In contrast, there was
no significant difference between the maximal
%LAA of the control subjects with and
without a history of smoking. A smoking
history had a significant effect on the maxi-
mal %LAA of the asthmatics, but not the
normal subjects. These results suggest that
smoking affects the maximal %LAA of the
lungs of asthmatic patients more signifi-
cantly than that of healthy subjects. Maxi-
mal %LAA was also correlated with
FEV1/FVC (r= -0.611, p<O.OOOl) and total
lung capacity (TLC) (r=0.391, p=0.0068) in
the asthmatics, which suggests that the
percentage of lung area with attenuation
values < -950 HU can be used for evaluating
the pathophysiology of asthma. However, the
correlation between maximal %LAA and TLC
was significant, but not highly significant,
perhaps because TLC was measured by the
helium dilution method. Since a significant
correlation did not exist between maximal
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%LAA and DLco in the asthmatics, this
suggests that the value of the maximal
%LAA does not directly implicate the pres-
ence of emphysematous lesions.
Gevenois, et al., showed that aging was
significantly related to an increase in %LAA
<- 950 HU; however, they did not find a
significant correlation between an increase in
%LAA and changes in total lung capacity
(TLC) 26l. In the present study, it can be
speculated that aging did not influence the
results because a significant difference in
maximal %LAA was not found between the
allergic asthma patients and the nonallergic
asthma patients, although the mean age of
these two groups of patients differed signifi-
cantly. The value of the maximal %LAA
was found to be associated with the severity
of asthma, but not with the type of asthma.
These results suggest that in asthma, a high
%LAA value on HRCT indicates more exten-
sive remodelling of the airways than a low
%LAA value.
The presence of emphysema in patients
with asthma is controversial. One recent
report suggested that none of the nonsmoking
asthma patients, including those with severe
asthma and those with asthma of long dura-
tion, had emphysema26l • Another report indi-
cated that at least some patients with
chronic, stable asthma develop a reduction in
computed tomography lung density, similar
to that in patients with emphysema29).
It is still unclear whether high %LAA in
asthma is due to hyperinflation and non-
emphysematous expiratory airflow limita-
tion, or to emphysematous lesions. However,
we speculate that both expiratory airflow
limitation and emphysematous lesions con-
tribute to the %LAA in asthmatics. Al-
though the subjects in our study are very old
for a study of asthmatics, we demonstrated
that the maximal %LAA is closely related
with the severity of asthma, even in subjects
which may include those with chronic ob-
structive pulmonary disease (COPD) and
emphysema. Further studies are necessary to
clarify the effects of hyperinflation and
airflow limitation on the CT quantification
of asthma.
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気管支嘱息における胸部HRCT所見の臨床[光延
文裕1]的意義
光延文裕O,御船尚志1),芦田耕三1),保崎泰弘1),
柘野浩史1),岡本 誠D,原田誠之1),中井陸郎2),
谷崎勝朗1)
1)岡山大学三朝分院内科, 2)放射線科
【目的】気管支瑞息症例において胸部HRCTを用
いて%LAA(Lowattenuationarea)を評価し,
臨床病態との関連を検討する｡
【対象と方法】気管支噂息症例81例ならびに健常
者22例を対象とした｡大動脈弓部,下葉分岐部,
横隔膜上3皿の3スライスを撮影し,胸部CT値の
演算によりCT値が-950HU以下の% LAA,さら
に3スライス中の最大% LAAと3スライスの平均
CT値を算出した｡その値と年齢,発症年齢,羅病
期間,性別,喫煙歴,重症度,病型,肺機能との
関連を検討した｡
【結果】1.最大% LAAは平均CT値と強い相関
を示した(rニ 0ー.916,p<0.0001)0 2.最大%LA
Aは喫煙喋息患者において非喫煙鳴息患者,喫煙
ならびに非喫煙健常者に比較して喫煙者において
有意に高値を示した｡%LAAは喫煙者,非喫煙
者ともに重症例において有意に高値を示した｡3.
最大%LAAは肺機能では1秒率(rニー0.611,
p<0.0001),全肺気量(r--0.391,p<0.0001)と
有意な相関を示した｡4.最大%LAAは噛息の重
症度とは有意の竿間を示したが,病型とは関連は
見られなかった｡
【考案】噛息患者におけるHRCTによる最大%L
AAは喫煙,重症度,肺機能と関連を示しており,
気管支喋息の臨床病態を反映する可能性が示唆さ
れた｡
